Pancreatic Cancer Research

ResearcherCarolinas Medical CenterNo recent work listed

Dionisios V. Vrochides

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2362-7573; OpenAlex author ID A5085910837. Sources: ClinicalTrials.gov.

Their work

Papers
7
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2015: 1 paper · 2016: 1 trial · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 1 paper

Papers 7

  1. Robotic versus laparoscopic distal pancreatectomy for pancreatic adenocarcinoma in obese patients. Co-author DOI 10.1002/rcs.2596↗
  2. The treatment sequence may matter in patients undergoing pancreatoduodenectomy for early stage pancreatic cancer in the era of modern chemotherapy. Co-author DOI 10.1016/j.amjsurg.2020.10.030↗
  3. Oncologic Outcomes of Robotic Left Pancreatectomy for Pancreatic Adenocarcinoma: A Single-Center Comparison to Laparoscopic Resection. Co-author DOI 10.1177/0003134820949524↗
  4. Pure and Hybrid Deep Learning Models can Predict Pathologic Tumor Response to Neoadjuvant Therapy in Pancreatic Adenocarcinoma: A Pilot Study. Co-author DOI 10.1177/0003134820982557↗
  5. Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database. Co-author DOI 10.1089/pancan.2020.0011↗
  6. Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National… Co-author DOI 10.3747/co.26.4066↗
  7. Robotic pancreaticoduodenectomy for pancreatic adenocarcinoma: role in 2014 and beyond. Co-author DOI 10.3978/j.issn.2078-6891.2015.027↗

Trials 1

  1. HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma Principal investigator NCT02850874↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John B. Martinie · 7 shared papers, 2015–2023 · strength 0.80
  2. David A. Iannitti · 6 shared papers, 2015–2021 · strength 0.67
  3. Erin H. Baker · 6 shared papers, 2015–2021 · strength 0.67
  4. Lee Mayer Ocuin · 4 shared papers, 2020–2021 · strength 0.50
  5. Michael David Watson · 4 shared papers, 2020–2021 · strength 0.50
  6. Maria R. Baimas‐George · 2 shared papers, 2021 · strength 0.26
  7. Jimmy J. Hwang · 1 shared paper, 2021 · strength 0.13
  8. Laleh Golkar Melstrom · 1 shared paper, 2023 · strength 0.13
  9. Fabio Ausania · 1 shared paper, 2023 · strength 0.13
  10. Steven Alan White · 1 shared paper, 2023 · strength 0.13
  11. Riccardo Memeo · 1 shared paper, 2023 · strength 0.13
  12. Yuman Fong · 1 shared paper, 2023 · strength 0.13
  13. Dianrong Xiu · 1 shared paper, 2023 · strength 0.13
  14. Carolina González Abós · 1 shared paper, 2023 · strength 0.13
  15. Gregorio Di Franco · 1 shared paper, 2023 · strength 0.13
  16. Pier Cristoforo Giulianotti · 1 shared paper, 2023 · strength 0.13
  17. Luca Morelli · 1 shared paper, 2023 · strength 0.13
  18. Jennifer Lee Miller-Ocuin · 1 shared paper, 2020 · strength 0.11
  19. Michael J. Passeri · 1 shared paper, 2019 · strength 0.11
  20. Ryan Z. Swan · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.